DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▼ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C1306459 | Primary malignant neoplasm | GALNT12 | 79695 | polypeptide N-acetylgalactosaminyltransferase 12 | Q8IXK2 |
C1306459 | Primary malignant neoplasm | B4GALT3 | 8703 | beta-1,4-galactosyltransferase 3 | O60512 |
C1306459 | Primary malignant neoplasm | PIGS | 94005 | phosphatidylinositol glycan anchor biosynthesis class S | Q96S52 |
C1306459 | Primary malignant neoplasm | B4GALT5 | 9334 | beta-1,4-galactosyltransferase 5 | O43286 |
C1306459 | Primary malignant neoplasm | CHST3 | 9469 | carbohydrate sulfotransferase 3 | Q7LGC8 |
C1306459 | Primary malignant neoplasm | GAL3ST1 | 9514 | galactose-3-O-sulfotransferase 1 | Q99999 |
C1306459 | Primary malignant neoplasm | HS3ST2 | 9956 | heparan sulfate-glucosamine 3-sulfotransferase 2 | Q9Y278 |
C1306459 | Primary malignant neoplasm | GCNT3 | 9245 | glucosaminyl (N-acetyl) transferase 3, mucin type | O95395 |
C1306459 | Primary malignant neoplasm | HS3ST1 | 9957 | heparan sulfate-glucosamine 3-sulfotransferase 1 | O14792 |
C1306459 | Primary malignant neoplasm | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
C1306459 | Primary malignant neoplasm | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C1306459 | Primary malignant neoplasm | GALNS | 2588 | galactosamine (N-acetyl)-6-sulfatase | P34059 |
C1306459 | Primary malignant neoplasm | GALC | 2581 | galactosylceramidase | P54803 |
C1306459 | Primary malignant neoplasm | GFPT1 | 2673 | glutamine--fructose-6-phosphate transaminase 1 | Q06210 |
C1306459 | Primary malignant neoplasm | GBA | 2629 | glucosylceramidase beta | P04062 |
C1306459 | Primary malignant neoplasm | GLB1 | 2720 | galactosidase beta 1 | P16278 |
C1306459 | Primary malignant neoplasm | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C1306459 | Primary malignant neoplasm | GUSB | 2990 | glucuronidase beta | P08236 |
C1306459 | Primary malignant neoplasm | SUMF1 | 285362 | sulfatase modifying factor 1 | Q8NBK3 |
C1306459 | Primary malignant neoplasm | HEXA | 3073 | hexosaminidase subunit alpha | P06865 |
C1306459 | Primary malignant neoplasm | IDUA | 3425 | alpha-L-iduronidase | P35475 |
C1306459 | Primary malignant neoplasm | IDS | 3423 | iduronate 2-sulfatase | P22304 |
C1306459 | Primary malignant neoplasm | ARSA | 410 | arylsulfatase A | P15289 |
C1306459 | Primary malignant neoplasm | ARSB | 411 | arylsulfatase B | P15848 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024